Skip to content
healthcare.dev
Get a free key

DAPAGLIFLOZIN

NDC 69097-388, DAPAGLIFLOZIN, tablet, film coated, from Cipla USA Inc..

Product NDC
69097-388
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211535
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-388 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN PROPANEDIOL5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
69097-388-026909703880230 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-388-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a2f86c0a-ce78-4d06-b5d8-ed457c8e3614

  • NADAC price for package 69097038802

    GET /v1/drugs/nadac/69097038802

Use it

Look up 69097-388 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-388 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-388. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.